Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Osong Public Health Res Perspect > Volume 11(3); 2020 > Article
Review Article COVID-19 Outbreak in Malaysia
Asita Elengoe
Osong Public Health and Research Perspectives 2020;11(3):93-100.
DOI: https://doi.org/10.24171/j.phrp.2020.11.3.08
Published online: May 31, 2020
  • 65,535 Views
  • 3,667 Download
  • 58 Crossref
  • 88 Scopus

Department of Biotechnology, Faculty of Science, Lincoln University College, Selangor, Malaysia

*Corresponding author: Asita Elengoe, Department of Biotechnology, Faculty of Science, Lincoln University College, Selangor, Malaysia, Email: asitaelengoe@yahoo.com
• Received: April 17, 2020   • Revised: May 6, 2020   • Accepted: May 11, 2020

Copyright ©2020, Korea Centers for Disease Control and Prevention

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

  • In 2020 a significant threat to public health emerged. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic outbreak emerged in December 2019 from Wuhan City, Hubei Province, China and spread to the rest of the world. This disease was named COVID-19 by World Health Organization. To date (17th April 2020) a total of 2,230,439 cases of COVID-19; 150,810 cases of deaths and 564,210 recovered cases have been reported worldwide. In this review the SARS-CoV-2 morphology, pathogenic mechanism, similarities and differences between SARS-CoV and Middle East Respiratory Syndrome and severe acute respiratory syndrome, transmission mode, diagnosis, treatment, and preventive measures were investigated. The outbreak of COVID-19 from a Malaysian perspective was explored and mental health care during the COVID-19 outbreak was explored. To date, there is no vaccine or no specific treatment for COVID-19. Therefore, preventive measures are very important to prevent and control the rapid spread of the SARS-CoV-2 virus. Preparedness should be a priority for future pandemic outbreaks.
A continuous occurrence of an unknown acute respiratory tract infection was reported in Wuhan City, Hubei Province, China, since 12th December 2019, originating from the Hunan South China Seafood Market [1]. On the 7th January 2020, Chinese scientists isolated the unknown viral sample from an infected person and sequenced its genome using the next gene sequencing tool. They reported that the virus had 96.3% genetic similarity with a Yunnan bat coronavirus RaTG13 and 70% homology with severe acute respiratory syndrome coronavirus (SARS-CoV) [2]. On the 12th January 2020, the World Health Organization (WHO) announced the cause of this epidemic outbreak was a novel coronavirus discovered in 2019 (2019-nCoV) or SARS-CoV-2 and named the disease coronavirus disease 2019 (COVID-19) [3]. However, the answer to the origin of SARS-CoV-2 remains to be determined.
The SARS-CoV-2 spread rapidly to other countries including South Korea, Taiwan, Thailand, Singapore, Japan, Italy, Iran, Spain, USA, UK and was classified by the WHO as a pandemic on 12th March 2020 [3]. As of the 17th April 2020, there are a total of 2,230,439 cases of COVID-19; 150,810 cases of deaths and 564,210 recovered cases have been reported throughout the world [4]. The USA has had the highest number of cases of COVID-19 (686,431) and number of deaths (35,578) [4]. There have been 58,179 USA patients who have recovered from COVID-19 [4]. On the 17th April 2020, a total of 8,861 new cases and 961 new deaths were reported in USA [4]. The number of cases has increased exponentially in USA, Italy, Spain, UK, Turkey, and Russia. This article describes COVID-19 and its outbreak in Malaysia.
1. SARS-CoV-2

1.1. Morphology and pathogenic mechanism

The SARS-CoV-2 is a beta coronavirus, which is a large, spherical, enveloped, non-segmented positive-sense, single-stranded RNA virus genome of about 30 kb [5]. It consists of 4 main structural proteins which are spike glycoprotein (S), membrane (M), envelope (E) and nucleocapsid (N) proteins [6]. SARS-CoV-2 uses its spike to inhibit the activity of neutralizing antibodies. Neutralizing antibodies are mainly involved in preventing viral particles from interacting with the host cell to infect cells. S protein contains S1 and S2 domains and the interaction between the S1 domain of SARS-CoV-2 with a specific host cell receptor called Angiotensin Converting Enzyme 2 (ACE-2) promotes a conformational change in the S protein. The virus mediates membrane fusion with the host cell membrane via the S2 domain and enters the host cell (specifically alveolar epithelial cells) [7,8].

1.2. Similarities and differences between SARS-CoV, MERS-SARS and SARS-CoV-2

SARS-CoV-2 is different from SARS-CoV and MERS-SARS (Table 1) [3,913].

1.3. Transmission

SARS-CoV-2 spreads rapidly from person to person but it was initially hypothesized that, SARS-CoV-2 was propagated by animal to human via direct contact with an intermediary host. Consumption of infected, raw or semi-cooked meat may also lead to the transmission of the virus. COVID-19 is a zoonotic disease where an animal virus undergoes mutations that permit it to infect and replicate inside the human body where it spreads rapidly through the human population. The virus is transmitted by asymptomatic infected individuals and symptomatic individuals via oral fluid droplets, mainly airborne via coughing or sneezing [2,14,15].

1.4. Symptoms

COVID-19 symptoms are manifest usually as fevers, a dry cough and tiredness. Some infected individuals may have mild symptoms like headaches, muscle pains, runny nose, sore throat or diarrhea. Some COVID-19 patients may suffer from severe pneumonia, organ failure (e.g. kidney), acute respiratory tract infection and septic shock, which can lead to death [16]. However, there are some infected individuals who do not develop any symptoms and do not feel unwell. These people are called asymptomatic carriers. The people who are highly vulnerable to COVID-19 are the elderly, young children, pregnant ladies, and people with chronic diseases such as hypertension, diabetes, heart problems, kidney and liver diseases, in addition to immuno-compromised people including patients with cancer, HIV, auto-immune disorders, and smokers.

1.5. Treatment

To date, there is no vaccine or specific antiviral therapy confirmed by the WHO to be effective against COVID-19. However, there are a number of medicines which could potentially be repurposed to treat COVID-19 (Table 2) [14,1720].

1.6. Preventive measures

Since there is no safe and effective medicine against COVID-19, the WHO has developed a strict guideline to adhere to during the pandemic. Standard precautions are very important to set out and adhere to in an effort to curb the spread of SARS-CoV-2 worldwide. Preventive measures such as regular hand washing with soap or sanitizer, avoiding handshaking, wearing masks and gloves, social distancing of 1–2 m apart, coughing into disposable tissues or into a flexed elbow and self-isolating if symptomatic, avoidance of gatherings and unnecessary travel to affected areas can suppress the spread of viral infection.
2. COVID-19 in Malaysia
As of the 17th April 2020, there were 5,251 COVID-19 cases including 86 deaths and 2,967 cases of recovery reported by the Ministry of Health (MOH) in Malaysia [21]. Selangor, in Malaysia had recorded the highest number of confirmed COVID-19 cases (1,338) to date (17th April 2020). The government announced 27 districts as red zones including Lembah Pantai (592), Hulu Langat (446), Petaling Jaya (366), Seremban (288), Kuching (255), and Kluang (221), because of the large cumulative number of positive cases detected in those areas [21].
On the 25th January 2020, the first case of COVID-19 was detected in Malaysia and traced back to 3 Chinese nationals who previously had close contact with an infected person in Singapore [22,23]. They had travelled into Malaysia via Singapore on the 24th January 2020. They were treated at Sungai Buloh Hospital, Selangor, Malaysia [22,23]. The MOH quickly devised standard guidelines for the management of COVID-19 and 34 hospitals and screening centers were specifically designated in each state of Malaysia [including Kuala Lumpur Hospital (Kuala Lumpur), Sungai Buloh Hospital (Selangor), Tuanku Jaafar Hospital (Negeri Sembilan), Sultanah Aminah Hospital (Johor Bahru), Miri Hospital (Sarawak), Tawau Hospital (Sabah) [21].
The first Malaysian was confirmed with COVID-19 on the 4th February 2020. The 41-year old man had recently returned from Singapore when he started to develop a fever and a cough. He was quarantined at Sungai Buloh Hospital, Selangor [24]. On the same day, a 4-year-old Chinese national girl who had been isolated at Sultanah Maliha Hospital, Langkawi, since the 29th January 2020, had recovered, been discharged and was allowed to return to China [25]. In Malaysia, this was the first patient who had recovered from COVID-19 since the outbreak began.
A 40-year old female Malaysian was reported positive for COVID-19 on the 6th February 2020. She had no travel history to infected areas, however, she was the younger sister of the 41-year old man confirmed as positive with the virus on the 4th February 2020. She was the first COVID-19 patient in Malaysia who contracted the virus via local transmission. She developed a fever and a sore throat on 1st February 2020 and developed a cough the following day. She was isolated at Sultanah Bahiyah Hospital, Alor Setar, on the 3rd February 2020 [26]. On 12th March 2020, Malaysia reported its first sporadic case of COVID-19 where the infected person neither travelled to an affected area nor had contact with an infected person [21].
In March 2020, the number of reported COVID-19 cases grew relatively slowly until a religious event took place at Sri Petaling, Kuala Lumpur, which led to an exponential rise in cases [27]. A few weeks after the event, Malaysia recorded the highest number of positive cases of COVID-19 in South East Asia. The religious mass gathering was a 4-day event with 16,000 people participating, including 1,500 from outside Malaysia [27]. The spread of COVID-19 to other states of Malaysia and neighboring countries such as Brunei, Cambodia, Indonesia, Thailand, Singapore, Philippines and Vietnam was propagated [2831]. Sporadic cases of transmission within the local community were reported. A 53-year-old man who attended the religious event was confirmed as positive after returning Brunei. He was the first positive case of COVID-19 that was detected in Tutong, Brunei on 9th March 2020. His symptoms began to develop on 7th March 2020, and he was isolated at the National Isolation Centre in Tutong for treatment [32].
The number of positive cases increased beyond 553 cases on the 16th March 2020, and the Prime Minister of Malaysia announced a Movement Control Order (MCO). Social distancing was to be in place for 14 days (18th March to 31st March 2020) to reduce the rapid spread of COVID-19 [3335]. Since the 18th March 2020, the government restricted people from travelling to other states or COVID-19 affected areas. Only 1 person from 1 family could leave the home and go out to buy essential goods.
On the 17th March 2020, Malaysia confirmed 2 COVID-19 related deaths, a 60-year-old man from Kuching, Sarawak, who had a history of chronic disease, and a 34-year-old man from Johor Bahru, Johor, who participated at the religious gathering in Sri Petaling, Kuala Lumpur [36]. As the number of positive cases remained relatively high, on the 25th March 2020, the MCO was extended a further from 14 days to the 14th April 2020 [37].
Two more cluster groups were detected on 6th April 2020, originating from a religious gathering at Kuching, Sarawak, which led to 83 COVID-19 confirmed cases, and a wedding at Bandar Baru Bangi, Selangor, which resulted in 88 positive cases [38,39]. A new subcluster of COVID-19 cases was identified in Rembau, by the MOH on 8th April 2020. This subcluster was linked to the religious gathering at Sri Petaling, Kuala Lumpur. There were 27 people infected with SARS-CoV-2 virus [40].
As of the 10th April 2020, there were a total of 4,346 COVID-19 cases reported by the MOH Malaysia, including 70 deaths and 1,830 recovered cases [21]. Furthermore, the WHO estimated that the number of COVID-19 cases in Malaysia would grow exponentially and peak in mid-April and so the government extended the MCO a further 14 days until 28th April 2020 [41,42].
The government implemented an “Enhanced Movement Controlled Order (EMCO)” for specific areas in Kuala Lumpur including Kluang, Hulu Langat, Menara City One, Selangor Mansion, and Malayan Mansion effective until 28th April 2020 [43]. Residents who were under the EMCO were not permitted to leave their houses (the government provided food to the affected residents), receive visitors, or enter COVID-19 affected areas. All the residents had to be screened for COVID-19 by health officials. The MOH identified a new cluster of COVID-19 cases in Sendayan, Negeri Sembilan, on the 14th April 2020 where 39 people were identified as COVID-19 positive [44]. The MOH to date has reported 29 virus clusters throughout Malaysia. There were 69 COVID-19 positive cases reported by the MOH on 17th April 2020 [21] and this was the first time that the number of cases was less than 100 since the 14th March 2020.

2.1. Treatment of COVID-19 in Malaysia

A person was “suspected” of having COVID-19 based on the criteria below [21].
  1. Has acute respiratory infection (either with difficulty in breathing, sore throat, or dry cough) with or without fever AND

  2. Had a history of travel to or resided in a foreign country within 14 days before onset of disease OR

  3. Had close contact with an infected person in the last 14 days before the onset of symptoms

  4. Attended a gathering or event linked to a COVID-19 outbreak

A person was “confirmed” COVID-19 positive after performing laboratory tests.
COVID-19 patients can be diagnosed using diagnostic testing kits for the presence of the virus. Imaging techniques such as chest X-ray and pulmonary CT scans can be used to diagnose pneumonia in COVID-19 patients. There are 5 clinical stages of COVID-19 [21].
  • Stage 1. asymptomatic,

  • Stage 2. symptomatic and no pneumonia,

  • Stage 3. symptomatic and pneumonia,

  • Stage 4. symptomatic, pneumonia and supplemental oxygen required,

  • Stage 5. critically ill with multiorgan failure

Currently, there is no vaccine or specific treatment for COVID-19 that has been approved for use in humans. In Malaysia, hydroxychloroquine has been proposed as a drug to treat patients with COVID-19. Hydroxychloroquine inhibits endocytic pathways by elevating the pH of the endosomes to block the pH-dependent entry of the virus into the host cell [45]. The suggested treatment regime using hydroxychloroquine is
  • Stage 1. No treatment required

  • Stage 2. Hydroxychloroquine only

  • Stage 3/4. Hydroxychloroquine combined treatment with Lopinavir/Ritonavir

  • Stage 5. Hydroxychloroquine combined treatment with Lopinavir/Ritonavir, Ribavarin or Interferon Beta [21].

As of the 17th April 2020, the government reported that out of the 5,251 COVID-19 positive cases in Malaysia, 56.5% recovered [21].

2.2. Preventive measures in Malaysia

  • ✓ Wash hands frequently with soap and water or an alcohol-based hand sanitizer

  • ✓ Wear face mask and gloves

  • ✓ Maintain physical distancing of 1metre

  • ✓ Mass gatherings have been stopped

  • ✓ Cover mouth and nose with a disposable tissue or flexed elbow when coughing or sneezing

  • ✓ Avoid touching eyes, mouth, or nose

  • ✓ Avoid handshaking

  • ✓ Stay at home if immunocompromised or has comorbidities

  • ✓ Avoid traveling to COVID-19 affected areas or countries

  • ✓ Self-isolate at home for 14 days upon return from overseas if symptomatic

  • ✓ Screen for COVID-19 after a person returns from a foreign country

  • ✓ Avoid spreading false information regarding COVID-19

2.3. Movement Control Order (MCO) in Malaysia

In Malaysia, the Movement Control Order (MCO) was implemented on the 18th March and was in place until the 28th April to control the spread of COVID-19 nationwide. The government imposed 6 restrictions [46].
  • ✓ People were prohibited from attending mass gatherings such as religious, sports, social, and cultural events. All places of worship and businesses were closed temporarily. However, people could buy essential goods at markets, supermarkets, grocery shops and convenience stores.

  • ✓ People were required to undergo health screening for the detection of COVID-19 and self-isolate after returning from overseas.

  • ✓ Foreign tourists and visitors were forbidden entry to Malaysia.

  • ✓ Kindergartens, government, and private schools including daily schools, boarding schools, international schools, tahfiz centers, other primary, secondary and pre-university institutions were all closed.

  • ✓ Public and higher education institutions and skill training institutes nationwide were closed.

  • ✓ Government and private premises were closed except for essential services (water, electricity, energy, telecommunications, postal, transportation, irrigation, oil, gas, fuel, lubricants, broadcasting, finance, banking, health, pharmacy, fire, prison, port, airport, safety, defense, cleaning, retail and food supply).

2.4. Psychological stress during pandemic outbreak of COVID-19 in Malaysia

Anyone can be affected emotionally during an outbreak like COVID-19. Everyone reacts differently to critical scenarios. Fear, worry, and anxiety regarding COVID-19 can cause strong emotions such as stress and depression in a person. For example, a 62-year old patient under investigation for COVID-19, committed suicide in Serdang Hospital, Selangor, apparently due to depression [47,48]. The MOH has published well-described guidelines on “Mental Health and Psychosocial Support in COVID-19 [21].” They included the mental health and psychosocial support services for individuals under COVID-19 investigation and those health care workers/response workers involved. A concise flow chart of mental health and psychosocial support activities for COVID 19 were described in the guideline [21]. Some mental health care tips are listed below:
  • ✓ Eat healthy food

  • ✓ Drink lots of water

  • ✓ Do regular physical exercise indoors

  • ✓ Perform deep breathing exercises

  • ✓ Practice yoga/meditation

  • ✓ Listen to music

  • ✓ Be artistic and expressive

  • ✓ Read books

  • ✓ Cook and bake (new recipes)

  • ✓ Spend quality time with family members

  • ✓ Talk with friends

This COVID-19 pandemic outbreak continues to have a strong impact on the economy, trade, and tourism industries. It has also affected sports activities such as the 2020 SUKMA Games, squash’s Asian Team Championship, and the 2020 Summer Olympics was postponed until 2021. To date, there is no specific treatment for COVID-19. Worldwide, many clinical trials are being carried out to find medicines and vaccines for COVID-19. At the same time, the experience gained from the global efforts in dealing with COVID-19, should propel countries globally to be prepared for disease control for novel disease outbreaks, epidemics and pandemics of the future.
I would like to thank the MOH in Malaysia and many professions including doctors, nurses, police officers, soldiers, garbage collectors, and cleaners who have been at the forefront in responding to the pandemic COVID-19 outbreak. I would like to thank specifically Dato Dr. Noor Hisham Abdullah who is the Director-General of Health Malaysia. Every day, Dato provides the necessary information and updates of COVID-19 to the country. Lastly, I greatly appreciate the COVID-19 cases whose information was used for this review.

Conflicts of Interest

The author has no conflict of interest to declare.

Table 1
The similarities and differences between the severe acute respiratory syndrome coronavirus (SARS-CoV), the Middle East respiratory syndrome coronavirus (MERS-CoV) and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
SARS-CoV MERS-SARS SARS-CoV-2
Coronaviriniae Genera b-coronavirus, lineage B b-coronavirus, lineage C b-coronavirus, lineage B
Virus type RNA virus RNA virus RNA virus
Total length of DNA sequence 29,751 30,111 29,903
Discovery (y) 2003 2012 2019
Origin Guangdong province, China Arabian Peninsula Hubei province, China
Total No. of cases worldwide (WHO report) > 8,000 2,494 2,230,439 (Till 17th April 2020)
Total No. of affected countries (WHO report) 26 27 210
Total number of death cases (WHO report) 916 858 150,837 (As of 17th April 2020)
Mortality >10% 34.4% 2.10%
Transmission mode -Droplets (coughing and sneezing)
-Close contact with an infected person
-Droplets (coughing and sneezing)
-Close contact with an infected person
-Droplets (coughing and sneezing)
-Close contact with an infected person or even asymptomatic ones
Transmission medium Animal to human
Human to human
Animal to human
Human to human
Animal to human
Human to human
Transmission region Globally Regionally Globally
Cellular receptor Angiotensin-Converting Enzyme 2 (ACE 2) Dipeptidyl peptidase 4 (DDP4) Angiotensin-Converting Enzyme 2 (ACE2)
Reservoir Palm Civets and Bats Bats and Camels Bats
Receptor binding domain (RBD) C-domain C-domain C-domain
IFN-γ inhibitor Yes Yes Unknown
Viral replication efficiency High Higher Higher
Pathogenicity Higher High High
Clinical symptoms (WHO report) Fever, malaise, myalgia, headache, diarrhea, and shivering (rigors) Fever, cough, and shortness of breath Fever, tiredness, and dry cough
Prevention -Hand wash
-Wear mask and gloves
-Physical distancing
-Hand wash
-Wear mask and glove
-Physical distancing
-Hand wash
-Wear mask and gloves
-Physical distancing
Treatment Glucocorticoid and interferon No vaccine or specific treatment No specific antiviral treatment

MERS-CoV = Middle East respiratory syndrome coronavirus; SARS-CoV = severe acute respiratory syndrome coronavirus; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; WHO = World Health Organization.

Table 2
Drugs and their potential mechanisms for inhibiting SARS-CoV-2 infection in humans.
Drugs Mechanism
Remdesivir Blocks viral RNA-dependent RNA polymerase activity (inhibits RNA replication from the RNA template)
Chloroquine and hydroxychloroquine Inhibits endocytosis by increasing the acidity in endosomes and prevents the entry of virus into the host cell.
Lopinavir and ritonavir Inhibits RNA translation process
Lopinavir and ritonavir plus interferon-beta Inhibits viral replication
Camostat mesylate Inhibits enzymatic activity of type II transmembrane serine protease (TMPRSS2) which is important for infectious viral entry into the host cell
Darunavir Blocks viral replication
BCR-ABL kinase inhibitor imatinib Inhibits fusion of virions with the endosomal membrane
Arbidol Inhibits membrane fusion of the viral envelope
Ribavarin Inhibits viral RNA synthesis and mRNA capping
Ribavirin plus interferon-beta Shuts down viral replication
Umifenovir Inhibits fusion of virions with the endosomal membrane
Oseltamivir Inhibits RNA translation process
Interferon-beta Triggers the activation of innate antiviral immunity
Favipiravir Blocks viral RNA-dependent RNA polymerase activity (inhibits RNA replication from RNA template)
Monoclonal antibodies Inhibits viral infection via binding to the virus

SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • The role of religion in mitigating the COVID-19 pandemic: the Malaysian multi-faith perspectives
      Min Min Tan, Ahmad Farouk Musa, Tin Tin Su
      Health Promotion International.2022;[Epub]     CrossRef
    • Older people and responses to COVID‐19: A cross‐sectional study of prevention practices and vaccination intention
      Li Ping Wong, Haridah Alias, Yi Ru Tan, Kit Mun Tan
      International Journal of Older People Nursing.2022;[Epub]     CrossRef
    • Property development during the COVID-19 pandemic: challenges and outlook in Malaysia
      Zainab T. Jagun, Bemgba B. Nyakuma, Dzurllkanian Daud, Salfarina Samsudin
      Environmental Science and Pollution Research.2022;[Epub]     CrossRef
    • Vaccine hesitancy in East Malaysia (Sabah): A survey of the national COVID-19 immunisation programme
      Adi Jafar, Mohammad Tahir Mapa, Nordin Sakke, Ramli Dollah, Eko Prayitno Joko, Colonius Atang, Syahruddin Awang Ahmad, Chong Vun Hung, Fionna Geogre
      Geospatial Health.2022;[Epub]     CrossRef
    • The impact of COVID-19 non-pharmaceutical interventions on the lived experiences of people living in Thailand, Malaysia, Italy and the United Kingdom: A cross-country qualitative study
      Mira L. Schneiders, Bhensri Naemiratch, Phaik Kin Cheah, Giulia Cuman, Tassawan Poomchaichote, Supanat Ruangkajorn, Silvia Stoppa, Anne Osterrieder, Phee-Kheng Cheah, Darlene Ongkili, Wirichada Pan-ngum, Constance R. S. Mackworth-Young, Phaik Yeong Cheah,
      PLOS ONE.2022; 17(1): e0262421.     CrossRef
    • COVID-19 in Southeast Asia: current status and perspectives
      Dinh-Toi Chu, Suong-Mai Vu Ngoc, Hue Vu Thi, Yen-Vy Nguyen Thi, Thuy-Tien Ho, Van-Thuan Hoang, Vijai Singh, Jaffar A. Al-Tawfiq
      Bioengineered.2022; 13(2): 3797.     CrossRef
    • One-year comparative assessment of retention of arch width increases between modified vacuum-formed and Hawley retainers:
      Asma Ashari, Lew Xian, Alizae Marny Fadzlin Syed Mohamed, Rohaya Megat Abdul Wahab, Yeoh Chiew Kit, Malathi Deva Tata, Sindhu Sinnasamy, Elavarasi Kuppusamy
      The Angle Orthodontist.2022; 92(2): 197.     CrossRef
    • Cyanobacteria and Algae-Derived Bioactive Metabolites as Antiviral Agents: Evidence, Mode of Action, and Scope for Further Expansion; A Comprehensive Review in Light of the SARS-CoV-2 Outbreak
      Biswajita Pradhan, Rabindra Nayak, Srimanta Patra, Prajna Paramita Bhuyan, Soumya Ranjan Dash, Jang-Seu Ki, Siba Prasad Adhikary, Andrea Ragusa, Mrutyunjay Jena
      Antioxidants.2022; 11(2): 354.     CrossRef
    • Whole genome sequence analysis showing unique SARS-CoV-2 lineages of B.1.524 and AU.2 in Malaysia
      Ummu Afeera Zainulabid, Aini Syahida Mat Yassim, Mushtaq Hussain, Ayesha Aslam, Sharmeen Nellisa Soffian, Mohamad Shafiq Mohd Ibrahim, Norhidayah Kamarudin, Mohd Nazli Kamarulzaman, How Soon Hin, Hajar Fauzan Ahmad, Ahmed S. Abdel-Moneim
      PLOS ONE.2022; 17(2): e0263678.     CrossRef
    • Impact of COVID-19 on Malaysian dental students’ physical, mental, financial and academic concerns
      Widya Lestari, Nur Hazirah Yazid, Zawin Najah Azhar, Azlini Ismail, Cortino Sukotjo
      BMC Oral Health.2022;[Epub]     CrossRef
    • Clinical characteristics and risk factors for mortality in patients with COVID-19: A retrospective nationwide study in Malaysia
      Siti NA Ismail, Izzati Abdul Halim Zaki, Zakiah Mohd Noordin, Nur Sabiha Md Hussin, Long Chiau Ming, Hanis Hanum Zulkifly
      Proceedings of Singapore Healthcare.2022; 31: 201010582210857.     CrossRef
    • Prevalence of Anxiety and Depression among Psychiatric Healthcare Workers during the COVID-19 Pandemic: A Malaysian Perspective
      Mehul Kumar Narendra Kumar, Benedict Francis, Aili Hanim Hashim, Nor Zuraida Zainal, Rusdi Abdul Rashid, Chong Guan Ng, Mahmoud Danaee, Nurulwafa Hussain, Ahmad Hatim Sulaiman
      Healthcare.2022; 10(3): 532.     CrossRef
    • Country Wise Measures in Contrast to The Spread of SARS-COV2/COVID-19
      Hindustan Abdul Ahad, Haranath Chinthaginjala, Bhavani Haribabu Sai Dharani, Momin Umaira Ayisha, Chukkaluri Anu Reddy, Gandhodi Chandra Manasa, Nandini Nandini
      Asian Journal of Research in Pharmaceutical Scienc.2022; : 62.     CrossRef
    • Circadian Disruption and Occupational Toxicants Exposure Affecting the Immunity of Shift Workers During SARS CoV-2 Pandemic
      Siti Hanisah Mohd Fuad, Norsham Juliana, Nor Amira Syahira Mohd Azmi, Nur Islami Mohd Fahmi Teng, Sahar Azmani, Izuddin Fahmy Abu, Srijit Das
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • Addressing the COVID-19 pandemic challenges for operational adaptations of a cluster randomized controlled trial on dengue vector control in Malaysia
      Mitra Saadatian-Elahi, Neal Alexander, Tim Möhlmann, Farah Diana Ariffin, Frederic Schmitt, Jason H. Richardson, Muriel Rabilloud, Nurulhusna Ab Hamid
      BMC Public Health.2022;[Epub]     CrossRef
    • Epidemiological Features of COVID-19 Patients in Terengganu State of Malaysia and the Predictors for SARS-CoV-2 Transmissibility
      Hafizuddin Awang, Effah Leiylena Yaacob, Mohd Shafik Abd Majid, Azmani Wahab, Mohd Anuar Abd Rahman, Kasemani Embong
      European Journal of Medical and Health Sciences.2022; 4(2): 67.     CrossRef
    • The COVID-19 pandemic and herding behaviour among investors in Shariah-compliant stocks
      Khemaies Bougatef, Imen Nejah
      Journal of Islamic Accounting and Business Researc.2022; 13(5): 832.     CrossRef
    • A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
      Biswajita Pradhan, Rabindra Nayak, Srimanta Patra, Prajna Paramita Bhuyan, Pradyota Kumar Behera, Amiya Kumar Mandal, Chhandashree Behera, Jang-Seu Ki, Siba Prasad Adhikary, Davoodbasha MubarakAli, Mrutyunjay Jena
      Carbohydrate Polymers.2022; 291: 119551.     CrossRef
    • Risk Factors for Mortality among COVID-19 Patients in Besut Region, Terengganu, Malaysia
      Hafizuddin Awang, Effah Leiylena Yaacob, Arfizah Ahmad Daud, Normahizan Ahmad, Muhammad Solehuddin Ishak, Nur Almas Alias, Nor Hafizah Ghazali, Nur Farihin Ismail, Mohd Adli Abd Khalim, Saidah Adilah Mohamed Yusof, Siti Fatimah Samsury, Mohd Anuar Abd R
      European Journal of Medical and Health Sciences.2022; 4(3): 1.     CrossRef
    • Extending the Unified Theory of Acceptance and Use of Technology for COVID-19 Contact Tracing Application by Malaysian Users
      Mahmood Alshami, Rawad Abdulghafor, Abdulaziz Aborujilah
      Sustainability.2022; 14(11): 6811.     CrossRef
    • The Meaning in Life and Courage of Malaysian Frontliners During COVID-19
      Kalaivanan Syasyila, Lim Lee Gin, Zhooriyati Sehu Mohamad
      Pertanika Journal of Social Sciences and Humanitie.2022; 30(2): 623.     CrossRef
    • Individual mobility pattern in Malaysia during COVID‐19 Recovery Movement Control Order partial lockdown
      Uznir Ujang, Suhaibah Azri
      Geo: Geography and Environment.2022;[Epub]     CrossRef
    • Transmission parameters of coronavirus disease 2019 in South Asian countries
      Mridul Sannyal, Abul Mukid Md. Mukaddes
      Osong Public Health and Research Perspectives.2022; 13(3): 191.     CrossRef
    • Psychological First Aid Training during COVID-19 Pandemic: Evaluation of the Training Effects of Conducting Virtual Psychological First Aid Training in Malaysia
      Sue Kiat Tye, Hariyati Sharima Abdul Majid, Abdul Rahman Ahmad Badayai
      Malaysian Journal Of Psychiatry.2022; 31(1): 28.     CrossRef
    • A network analysis and support vector regression approaches for visualising and predicting the COVID-19 outbreak in Malaysia
      Siti Nurhidayah Sharin, Mohamad Khairil Radzali, Muhamad Shirwan Abdullah Sani
      Healthcare Analytics.2022; 2: 100080.     CrossRef
    • Incidence and prevalence of psoriasis in multiethnic Johor Bahru, Malaysia: a population‐based cohort study using electronic health data routinely captured in the Teleprimary Care ( TPC ® ) clinical informa
      Siew Eng Choon, Alison K. Wright, Christopher E.M. Griffiths, Kwee Eng Tey, Kit Wan Wong, Yoong Wei Lee, Ushananthiny Suvelayutnan, Jeevitha Mariapun, Darren M. Ashcroft
      British Journal of Dermatology.2022;[Epub]     CrossRef
    • Population-level public mental health intervention via interdisciplinary COVID-19 health crisis communication: how can occupational therapists contribute?
      J. Y. Teoh
      World Federation of Occupational Therapists Bullet.2021; 77(1): 10.     CrossRef
    • Nasopharyngeal diffuse large B-cells lymphoma causing acute airway obstruction amid COVID-19 crisis: an anaesthetist’s nightmare
      Tat Boon Yeap, Ming Kai Teah, Yen Ju Joanne Quay, Melvin Teck Fui Wong
      BMJ Case Reports.2021; 14(1): e241008.     CrossRef
    • Multistakeholder Participation in Disaster Management—The Case of the COVID-19 Pandemic
      Sigamani Panneer, Komali Kantamaneni, Robert Ramesh Babu Pushparaj, Sulochana Shekhar, Lekha Bhat, Louis Rice
      Healthcare.2021; 9(2): 203.     CrossRef
    • Factors Influencing Asia-Pacific Countries’ Success Level in Curbing COVID-19: A Review Using a Social–Ecological System (SES) Framework
      Gabriel Hoh Teck Ling, Nur Amiera binti Md Suhud, Pau Chung Leng, Lee Bak Yeo, Chin Tiong Cheng, Mohd Hamdan Haji Ahmad, Ak Mohd Rafiq Ak Matusin
      International Journal of Environmental Research an.2021; 18(4): 1704.     CrossRef
    • Exploring the Impact of the COVID-19 Pandemic on University Students’ Learning Life: An Integrated Conceptual Motivational Model for Sustainable and Healthy Online Learning
      Nabil Hasan Al-Kumaim, Abdulsalam K. Alhazmi, Fathey Mohammed, Nadhmi A. Gazem, Muhammad Salman Shabbir, Yousef Fazea
      Sustainability.2021; 13(5): 2546.     CrossRef
    • Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey
      Li Ping Wong, Haridah Alias, Afiqah Alyaa Md Fuzi, Intan Sofia Omar, Azmawaty Mohamad Nor, Maw Pin Tan, Diana Lea Baranovich, Che Zarrina Saari, Sareena Hanim Hamzah, Ku Wing Cheong, Chiew Hwa Poon, Vimala Ramoo, Chong Chin Che, Kyaimon Myint, Suria Zainu
      PLOS ONE.2021; 16(3): e0248916.     CrossRef
    • Psychological Consequences of the Delay in the Silent Mentor Programme During the COVID-19 Pandemic: Perspectives From Family Members of Silent Mentors
      Li Ping Wong, Sik Loo Tan, Haridah Alias, Thiam Eng Sia, Aik Saw
      OMEGA - Journal of Death and Dying.2021; : 003022282110009.     CrossRef
    • Scenario analysis of COVID-19 transmission dynamics in Malaysia with the possibility of reinfection and limited medical resources scenarios
      Amer M. Salman, Issam Ahmed, Mohd Hafiz Mohd, Mohammad Subhi Jamiluddin, Mohammed Ali Dheyab
      Computers in Biology and Medicine.2021; 133: 104372.     CrossRef
    • Construction Sector Contribution to Economic Stability: Malaysian GDP Distribution
      Wesam Salah Alaloul, Muhammad Ali Musarat, Muhammad Babar Ali Rabbani, Qaiser Iqbal, Ahsen Maqsoom, Waqas Farooq
      Sustainability.2021; 13(9): 5012.     CrossRef
    • Effects of Location-Specific Meteorological Factors on COVID-19 Daily Infection in a Tropical Climate: A Case of Kuala Lumpur, Malaysia
      Ezekiel Kaura Makama, Hwee San Lim, Pedro Jiménez-Guerrero
      Advances in Meteorology.2021; 2021: 1.     CrossRef
    • Can algae contribute to the war with Covid-19?
      Wen Yi Chia, Hanz Kok, Kit Wayne Chew, Sze Shin Low, Pau Loke Show
      Bioengineered.2021; 12(1): 1226.     CrossRef
    • Public KAP towards COVID-19 and Antibiotics Resistance: A Malaysian Survey of Knowledge and Awareness
      Chee Tao Chang, Ming Lee, Jason Choong Yin Lee, Nicholas Chor Teng Lee, Tsu Yin Ng, Asrul Akmal Shafie, Kah Shuen Thong
      International Journal of Environmental Research an.2021; 18(8): 3964.     CrossRef
    • Depression and Suicidal Ideation in a Sample of Malaysian Healthcare Workers: A Preliminary Study During the COVID-19 Pandemic
      Hajar Mohd Salleh Sahimi, Tuti Iryani Mohd Daud, Lai Fong Chan, Shamsul Azhar Shah, Farynna Hana Ab Rahman, Nik Ruzyanei Nik Jaafar
      Frontiers in Psychiatry.2021;[Epub]     CrossRef
    • The Influence of COVID-19-Induced Daily Activities on Health Parameters—A Case Study in Malaysia
      Mujahid Ali, Afonso R. G. de Azevedo, Markssuel T. Marvila, Muhammad Imran Khan, Abdul Muhaimin Memon, Faisal Masood, Najib Mohammed Yahya Almahbashi, Muhammad Kashif Shad, Mudassir Ali Khan, Roman Fediuk, Roman Timokhin, Aleksey Borovkov, Ihtisham Ul Haq
      Sustainability.2021; 13(13): 7465.     CrossRef
    • COVID-19 Death Risk Assessment in Iran using Artificial Neural Network
      R Adebayo Ifeoluwapo, Eko Supriyanto, Sahar Taheri
      Journal of Physics: Conference Series.2021; 1964(6): 062117.     CrossRef
    • Piecewise linear modelling and change-point analysis of COVID-19 outbreak in Malaysia
      P Phang, N A Abdul Taib, R Safii, J Labadin
      Journal of Physics: Conference Series.2021; 1988(1): 012105.     CrossRef
    • Proposal for development of a guideline in maintaining quality cancer care during and post-covid-19 in an upper middle-income country with universal health coverage
      Soo-Peng Teoh, Ros Suzanna Bustamam, Feisul Idzwan Mustapha, Cheng-Har Yip, Marniza Saad, Saunthari Somasundaram, Puteri Norliza Megat Ramli, Nik Daliana Nik Farid, Nirmala Bhoo-Pathy
      Journal of Cancer Policy.2021; 30: 100300.     CrossRef
    • Psychological distress, fear and coping among Malaysians during the COVID-19 pandemic
      Ahmed Suparno Bahar Moni, Shalimar Abdullah, Mohammad Farris Iman Leong Bin Abdullah, Mohammed Shahjahan Kabir, Sheikh M. Alif, Farhana Sultana, Masudus Salehin, Sheikh Mohammed Shariful Islam, Wendy Cross, Muhammad Aziz Rahman, Alessio Gori
      PLOS ONE.2021; 16(9): e0257304.     CrossRef
    • Depression and anxiety in Malaysian population during third wave of the COVID-19 pandemic
      Roy Rillera Marzo, Vineet Vinay, Rafidah Bahari, Shekhar Chauhan, Deborah Anak Fo Ming, Stephanie Fernandez A/P. Nelson Fernandez, Colin Cornelius Pereira Johnson, Agkesh Qumar A/L Thivakaran, Mohammad Meshbahur Rahman, Sonu Goel
      Clinical Epidemiology and Global Health.2021; 12: 100868.     CrossRef
    • The Cross-Sectional Relations of COVID-19 Fear and Stress to Psychological Distress among Frontline Healthcare Workers in Selangor, Malaysia
      Natasha Subhas, Nicholas Tze-Ping Pang, Wei-Cheng Chua, Assis Kamu, Chong-Mun Ho, Isabel Shamini David, William Wei-Liang Goh, Yogaraja Indran Gunasegaran, Kit-Aun Tan
      International Journal of Environmental Research an.2021; 18(19): 10182.     CrossRef
    • IoT MEMS: IoT-Based Paradigm for Medical Equipment Management Systems of ICUs in Light of COVID-19 Outbreak
      Abdulaziz Aborujilah, Abubaker-Eseddig Fathi Mahmoud Elsebaie, Shamsul Anuar Mokhtar
      IEEE Access.2021; 9: 131120.     CrossRef
    • On Analyzing Capnogram as a Novel Method for Screening COVID-19: A Review on Assessment Methods for COVID-19
      M. B. Malarvili, Mushikiwabeza Alexie, Nadhira Dahari, Anhar Kamarudin
      Life.2021; 11(10): 1101.     CrossRef
    • The Epidemiology of COVID-19 in Malaysia
      Vivek Jason Jayaraj, Sanjay Rampal, Chiu-Wan Ng, Diane Woei Quan Chong
      The Lancet Regional Health - Western Pacific.2021; 17: 100295.     CrossRef
    • Infectious Bronchitis Virus (Gammacoronavirus) in Poultry Farming: Vaccination, Immune Response and Measures for Mitigation
      Md. Safiul Alam Bhuiyan, Zarina Amin, Kenneth Francis Rodrigues, Suryani Saallah, Sharifudin Md. Shaarani, Subir Sarker, Shafiquzzaman Siddiquee
      Veterinary Sciences.2021; 8(11): 273.     CrossRef
    • Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
      Xin Ya Loke, Siti A. M. Imran, Gee Jun Tye, Wan Safwani Wan Kamarul Zaman, Fazlina Nordin
      International Journal of Molecular Sciences.2021; 22(22): 12421.     CrossRef
    • Global Pandemic as a Result of Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak: A Biomedical Perspective
      Charles Arvind Sethuraman Vairavan, Devarani Rameshnathan, Nagaraja Suryadevara, Gnanendra Shanmugam
      Journal of Pure and Applied Microbiology.2021; 15(4): 1759.     CrossRef
    • Clinician Wellness—Self-Care for Staying Healthy: Acupressure for Mental Wellness
      Yun Jin Kim
      Alternative and Complementary Therapies.2021; 27(6): 265.     CrossRef
    • Knowledge, Perceived Risk, and Preventive Behaviors amidst Covid-19 Pandemic among Dental Students in Malaysia
      Azlini Ismail, Nur Hanisah Ismail, Nur Yasrin Maisarah Abu Kassim, Widya Lestari, Ahmad Faisal Ismail, Cortino Sukotjo
      Dentistry Journal.2021; 9(12): 151.     CrossRef
    • Assessment of Impact of Containment During the COVID-19 Epidemic and Coping Behaviours Using Newly Developed Assessment Tools
      Li Ping Wong, Haridah Alias, Mahmoud Danaee, Hai Yen Lee, Kit Mun Tan, Peter Seah Keng Tok, Mustakiza Muslimin, Sazaly AbuBakar, Yulan Lin, Zhijian Hu
      Frontiers in Public Health.2021;[Epub]     CrossRef
    • Impact of lockdown on rheumatology outpatient care in the age of COVID-19
      Benjamin Sachdev Manjit Singh, Seow Lin Chuah, Yaw Kiet Cheong, Sharifah Aishah Wan, Cheng Lay Teh
      Annals of the Rheumatic Diseases.2020; : annrheumdis-2020-218484.     CrossRef
    • Doctors’ Mental Health in the Midst of COVID-19 Pandemic: The Roles of Work Demands and Recovery Experiences
      Mohd Fadhli Mohd Fauzi, Hanizah Mohd Yusoff, Rosnawati Muhamad Robat, Nur Adibah Mat Saruan, Khairil Idham Ismail, Ahmad Firdaus Mohd Haris
      International Journal of Environmental Research an.2020; 17(19): 7340.     CrossRef
    • SARS-CoV-2 lineage B.6 was the major contributor to early pandemic transmission in Malaysia
      Yoong Min Chong, I-Ching Sam, Jennifer Chong, Maria Kahar Bador, Sasheela Ponnampalavanar, Sharifah Faridah Syed Omar, Adeeba Kamarulzaman, Vijayan Munusamy, Chee Kuan Wong, Fadhil Hadi Jamaluddin, Yoke Fun Chan, Susanna Kar Pui Lau
      PLOS Neglected Tropical Diseases.2020; 14(11): e0008744.     CrossRef


    PHRP : Osong Public Health and Research Perspectives